Concluding today’s volatile trading session, Sensex recovered by 448 points from its today’s low of 44,169 levels to close at 44,618.04 levels down, by a mere 0.08 per cent or 37.40 points compared to its previous close. On the other hand, Nifty closed in green, up by 0.04 per cent or 4.70 points at 13,113.75 levels.

Rhizen Pharmaceuticals, a clinical-stage oncology-focussed biopharmaceutical company, and wholly-owned subsidiary of Alembic Pharma announced on Wednesday, the approval of its Investigational New Drug (IND) application by the US drug regulator, the United States Food and Drug Administration (USFDA) to study its oral DHODH inhibitor for SARS-CoV-2 infection.

Further, during Q2FY21, the total FDI inflows came in at USD 28,102 million. Out of which, equity inflows stood at USD 23,441 million or Rs 174,793 crore. With this, the total FDI equity inflow in FY21 stood at USD 30,004 million, 15 per cent greater than that of the corresponding period last year.

The market opened in red on December 02, 2020.

The market opened in red on December 02, 2020, overall volumes in futures & options currently stand at 2,07,73,356 contracts with a turnover of Rs. 17,48,724.93 crore.

The market opened in red on December 02, 2020, overall volumes in futures & options currently stand at 2,07,73,356 contracts with a turnover of Rs. 17,48,724.93 crore.

The company has received an order worth Rs 3,905 crore exclusive of GST in the month of November. Out of the four orders, one belongs to the water division amounting to Rs 848 crore and the remaining three orders belong to the building division worth Rs 3,057 crore. 

UPL: In the light of the strong performance in the first half and business prospects of the second half, driven by favourable agronomic conditions and strong agri-commodity prices, the group decided to redeem the notes early, from the cash in hand and de-leverage the balance sheet.

After recording an inflow of a whopping Rs 65,317.13 crore in the month of November, the strong buying by FIIs showed no signs of abating during the first session of December as they turned net buyers to the tune of Rs 3,242 crore. Overall, the market breadth was healthy and participation was seen across the board.

The trend remains in the favour of the bulls and now, the key level to watch out for is the level of 13,145 as sustaining above this level would help to negate the bearish implication of the bearish engulfing pattern. Meanwhile, on the downside, the level of 12,900 is a crucial support level.